TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ) Institutional Ownership

Q: What is CUSIP 89357L402?

CUSIP 89357L402 is the security identifier used in SEC filing datasets for RNAZ - TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value.

Q: Who owns RNAZ - TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CUSIP: 89357L402

13F Institutional Holders and Ownership History from Q4 2024 to Q2 2025

Type / Class: Equity / Common Stock, $0.0001 par value
Symbol: RNAZ on Nasdaq
Shares outstanding: 700,000
Price per share: $0.35

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 89357L402?
CUSIP 89357L402 identifies RNAZ - TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 89357L402:

Q2 2025 (0 holders) Q1 2025 (15 holders) Q4 2024 (4 holders)

Significant Owners of TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
SABBY MANAGEMENT, LLC	9.9%		$26,431		69,555		SABBY MANAGEMENT, LLC	31 Dec 2024
Tracy Thomas Joseph	5%		$13,300		35,000		Thomas Joseph Tracy	07 Mar 2025
Anson Funds Management LP	0.1%	-98%	$9,494	-$30,224	27,125	-76%	Anson Funds Management LP	30 Jun 2025

Institutional Holders of TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Price (Median)	Investors
2025 Q2	0	$0	-$1,053,827	$0.35	0
2025 Q1	2,128,495	$1,053,827	+$1,048,922	$0.50	15
2024 Q4	9,910	$33,396	+$33,396	$3.37	4